UnknownNCT03494738
Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorder
Studying Fetal alcohol syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CAMC Health System
- Principal Investigator
- Stefan Maxwell, MDCAMC Women and Children's Hospital
- Enrollment
- 600 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2022
Study locations (1)
- CAMC - Women and Children's Hospital, Charleston, West Virginia, United States
Collaborators
United States Drug Testing Laboratories, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03494738 on ClinicalTrials.govOther trials for Fetal alcohol syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07016009Thrive Person-Centered Planning Program for Young Adults With Fetal Alcohol Spectrum DisordersUniversity of Rochester
- RECRUITINGNANCT05686473Psychoeducation of Parents to Children With FASDSorlandet Hospital HF
- RECRUITINGNANCT06847165Trigeminal Nerve Stimulation for Children With Prenatal Alcohol ExposureUniversity of California, Los Angeles
- ENROLLING BY INVITATIONNANCT06935461Families Moving Forward Bridges: An Early Intervention for Infants and Toddlers With PAE With or At-risk for FASDUniversity of Washington
- RECRUITINGNANCT06638463My Health Coach App RCTUniversity of Rochester
- RECRUITINGNANCT05960461Families Moving Forward (FMF) Connect Pro for Mental Health ProvidersUniversity of Rochester
- RECRUITINGNANCT06005181The Synchrony Study: Examining Music Training for Children With FASDThe Mind Research Network
- RECRUITINGPHASE2NCT04395196RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol ExposureWayne State University